Status:

COMPLETED

Progesterone in Expectantly Managed Early-onset Preeclampsia

Lead Sponsor:

Assiut University

Conditions:

Preeclampsia

Eligibility:

FEMALE

Phase:

PHASE4

Brief Summary

Preeclampsia is a disorder of widespread vascular endothelial malfunction and vasospasm that occurs after 20 weeks' gestation and can present as late as 4-6 weeks postpartum

Detailed Description

Currently there is no effective treatment for early-onset preeclampsia except for early delivery of the fetus along with the placenta. Progesterone supplementation in the form of 17-alpha-hydroxyproge...

Eligibility Criteria

Inclusion

  • Gestational age between 20+0 and 33+6 weeks.
  • Singleton pregnancy.
  • Willing to participate in the study and sign the informed consent.

Exclusion

  • Maternal compromise requiring emergent delivery (ongoing placental abruption, DIC, pulmonary edema).
  • Fetal compromise requiring emergent delivery (fetal bradycardia, recurrent late fetal heart rate decelerations).
  • Platelet count \< 100,000/microliter (thrombocytopenia) with evidence of HELLP syndrome;
  • Persistently abnormal hepatic enzyme concentrations (twice or more upper normal values);
  • Severe fetal growth restriction (ultrasound-estimated fetal weight less than fifth percentile);
  • Severe Oligohydramnios (AFI \< 5cm)
  • Reversal of end diastolic flow(REDF) in umbilical artery Doppler testing;
  • Eclampsia;
  • Nonreassuring fetal status during daily testing (biophysical profile \<4/10 and/or recurrent variable or late decelerations);
  • Intrauterine fetal death.
  • Patient is unable or unwilling to give consent.
  • Patients currently using progesterone for other indications.

Key Trial Info

Start Date :

December 15 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 15 2022

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT04077853

Start Date

December 15 2019

End Date

January 15 2022

Last Update

May 9 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ahmed Abbas

Assiut, Cairo Governorate, Egypt, 002